Immunotherapy agent benefits patients with drug-resistant multiple myeloma
Wednesday, August 26, 2015 - 20:30
in Health & Medicine
In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments, investigators report.